Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men

In-vitro studies have suggested that the antiarrhythmic drug digoxin might restrain the growth of cancer cells by inhibiting Na+/K+-ATPase. We evaluated the association between cancer mortality and digoxin, sotalol and general antiarrhythmic drug use in a retrospective cohort study. The study popula...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Kaapu, Kalle J., Rantaniemi, Lauri, Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo L. J., Auvinen, Anssi, Murtola, Teemu J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037774/
https://ncbi.nlm.nih.gov/pubmed/29985440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-28541-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak